https://www.nasdaq.com/market-activity/stocks/ivbxf/news-headlines
Innovent Biologics Inc (IVBXF) News Headlines | Nasdaq
Stay up-to-date on Innovent Biologics Inc (IVBXF) news with the latest updates, breaking headlines, news articles, and more from around the web at Nasdaq.com.
innovent biologicsnews headlinesincnasdaq
https://www.ig.com/uk/shares/markets-shares/innovent-biologics-inc
Trade Innovent Biologics Inc Shares | Live Innovent Biologics Inc Share Price | IG UK - IG UK
Innovent Biologics Inc is an investment holding company principally engaged in the research, development, production and sales of innovative... [UK]
innovent biologicslive sharetradeincshares
https://chambers.com/articles/junhe-facilitates-iaso-biotechnology-and-innovent-biologics-collaboration-on-fucaso
JunHe facilitates IASO Biotechnology and Innovent Biologics' collaboration on FUCASO | Highlight |...
This Highlight gives an overview about "JunHe facilitates IASO Biotechnology and Innovent Biologics' collaboration on FUCASO". Find out more on Chambers and...
innovent biologicsjunheiasobiotechnology
https://www.prnewswire.co.uk/news-releases/innovent-biologics-and-synaffix-expand-adc-collaboration-following-positive-preliminary-clinical-signal-from-ongoing-phase-1-study-302008012.html
Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical...
/PRNewswire/ -- Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for the development of...
innovent biologicssynaffixexpand
https://www.biospace.com/press-releases/asco-2025-oral-presentation-innovent-biologics-announces-updated-data-of-ibi343-novel-anti-cldn18-2-adc-from-the-phase-1-clinical-study-in-patients-with-advanced-pancreatic-cancer
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel...
oral presentationinnovent biologics
https://www.mdanderson.org/newsroom/md-anderson-and-innovent-biologics-announce-a-strategic-collaboration-to-develop-anti-pd-1-therapy-tyvyt-sintilimab-injection-in-rare-cancers.h00-159381945.html
MD Anderson and Innovent Biologics announce a strategic collaboration to develop anti-PD-1 therapy...
MD Anderson and Innovent Biologics have announced a strategic collaboration agreement to co-develop Innovent's anti-PD-1 monoclonal antibody for treating rare...
https://www.biospace.com/press-releases/asco-2025-oral-presentation-innovent-biologics-announces-updated-data-of-ibi363-first-in-class-pd-1-il-2%CE%B1-bias-bispecific-antibody-fusion-protein-from-phase-1-and-2-clinical-studies-on-immunotherapy-treated-advanced-malignant-melanoma
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class...
https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/it-looks-like-the-ceo-of-innovent-biologics-inc-hkg1801-may
It Looks Like The CEO Of Innovent Biologics, Inc. (HKG:1801) May Be Underpaid Compared To Peers -...
Key Insights Innovent Biologics will host its Annual General Meeting on 25th of June Total pay for CEO Michael Yu...